Novartis Earnings Narrowly Top; Drug Giant Rises In Buy Zone

Novartis Earnings Narrowly Top; Drug Giant Rises In Buy Zone

Source: 
Investors Business Daily
News Tags: 
snippet: 

Novartis stock edged higher early Wednesday, still in a buy zone, after the Swiss pharmaceutical company reported adjusted earnings of $1.32 per share on $12.4 billion in sales for its fourth quarter.